Senior VC Associate @ MMRF in Remote

The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit http://www.themmrf.org.

MIF Overview:

The Myeloma Investment Fund (MIF) is an evergreen venture philanthropy fund and wholly owned subsidiary of the Multiple Myeloma Research Foundation (MMRF), focused on accelerating the development of transformative therapies for myeloma patients. The MIF invests in seed- through clinical-stage private biotech companies with the goal of bringing new therapies to multiple myeloma patients. Since its inception 2019, the MIF has invested in 12 companies pursuing a wide range of novel therapeutic technologies and targets. The fund is supported entirely by donated capital, and 100% of financial returns are reinvested to drive the continued development of new myeloma therapies. In addition to capital, the MIF seeks to add value by supporting portfolio companies with the scientific and clinical expertise of the MMRF.

MMRF Core Values:

At the MMRF, our core values define both who we are and how we work together as an organization. We believe in investing in our team and building a culture that will help us pursue our highest level mission to accelerate a cure for each and every multiple myeloma patient. Our five core values are expressed below:

1. Prioritize Patients – Patients are at the center of everything we do. Every decision we make is grounded in the needs and best interests of the patients we serve.

2. Drive Innovation – We are committed to pursuing big, bold ideas. Taking risks, trying new approaches, and challenging the status quo are necessary to speed new discoveries.

3. Deliver Solutions – Taking on complicated challenges is what sets us apart. To deliver results, we must be decisive, take action, and act with urgency on behalf of the myeloma community.

4. Do It Together – We know that together, we are stronger. We work cross-functionally with the entire community to achieve our mission and are invested in the success of others.

5. Build Trust – We build trust-based relationships. We advocate for each and every myeloma patient by committing to diversity, equity, and inclusion and treating others with respect.

Position Overview:

The MIF is seeking a creative, passionate, and driven Senior Associate to support the fund’s investment efforts. This is a unique opportunity to drive new investments for an oncology-focused philanthropic venture capital firm in a mission-driven environment. The Senior Associate will also build on MIF’s relationships with its current portfolio companies by working with company management on myeloma-specific projects and serving as a board member or observer.

Essential Functions:

• Drive deal flow: source and evaluate prospective deals (including scientific, operational, and financial due diligence)
• Work with MMRF experts, the MIF Scientific Advisory Board, and legal counsel to conduct diligence. Prepare investment memos and present to MIF Investment Committee.
• Support the MIF’s responsibilities in board member or observer roles
• Assist with portfolio company management and ensure portfolio companies can maximize the benefit of MMRF expertise/resources to support their programs
• Lead market research and sourcing efforts aimed at identifying new investment trends and opportunities in myeloma and in oncology/immunotherapy more broadly
• Network with peers at other venture capital firms and industry partners
• Be a thought leader, maintain up-to-date knowledge on industry and technology trends, attend and speak at events/conferences
• Other duties as assigned by the Managing Director, Principal, or designee

Qualifications:

• Minimum: PhD in the biomedical field or MD required; background in immunology/oncology strongly preferred
• 3+ years’ work experience with exposure to the healthcare industry; experience in an investing role strongly preferred; consulting or other strategic roles also considered
• Experience with investment deal flow (sourcing, due diligence, closing) strongly preferred
• Understanding of scientific, clinical, operational, and financial drivers that impact decision-making in biotech and healthcare
• Demonstrated problem-solving, quantitative, and qualitative analysis skills, including familiarity with financial modeling and valuation techniques
• Intellectual curiosity and enthusiasm for the oncology-focused healthcare industry
• Highly collaborative work style, pragmatic, and resourceful problem-solver
• Strong communication skills (written, verbal, listening, and presentation)
• Approaches work with the highest level of personal ownership: responsibility, accountability, integrity, and ethics
• Capability and desire to build relationships and network within the myeloma scientific community and healthcare industry
• Must be mission driven and passionate about the myeloma patient community; desire to utilize outstanding scientific acumen to help cure multiple myeloma
• Ability to travel (10%)